michigan semaglutide intestinal paralysis class action glp-1 Ozempic/GLP-1 Drug Class Action Case Study glp-1 bowel obstruction class action

Report side effects and health changes during follow-up

Florence Mussat is a board-certified plastic and reconstructive surgeon, and is proud to offer her patients Semaglutide and Tirzepatide treatment management in Chicago

February 26, 2026: Competitors New GLP-1 Tablet May Have More Side Effects in Head-to-Head Clinical Trial Against Rybelsus Novo Nordisks competitor (Eli Lilly) is developing an oral GLP-1 pill (i.e., orforglipron) that is similar to Rybelsus

1S) and Eggers tests indicated no significant publication bias for most endpoints, including CV death (p = 0.858), expanded MACE (p = 0.223), nonfatal MI (p = 0.867), and nonfatal stroke (p = 0.310)

References: Maselli, D

The catch: most of the strong data on GLP-1 anti-inflammatory effects comes from studies done at standard clinical doses, not microdoses